ITGAM and neoplasm: Our experimental groups, namely: 1) CD11b+ cells from spleens of c26GM colon cancer ; 2) CD11b+ cells from tumor infiltrates of c26GM colon cancer ; and 3) CD11b+ cells from tumor infiltrates of 4T1 breast cancer have been chosen based on the aforementioned dataset.